Arbutus Biopharma ABUS
3.3
0.01
0.3
%
已收盤:05/08 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
---|---|---|---|---|---|---|
2024Q4 | 3.27 | 111.45 | -0.07 | -13,933 | -13 | |
2024Q3 | 3.85 | 108.90 | -0.10 | -21,440 | -20 | |
2024Q2 | 3.09 | 109.21 | -0.11 | -21,583 | -20 | |
2024Q1 | 2.58 | 108.59 | -0.10 | -19,363 | -18 | |
2023Q4 | 2.50 | 107.68 | -0.12 | -20,747 | -19 | |
2023Q3 | 2.03 | 107.48 | -0.12 | -21,558 | -20 | |
2023Q2 | 2.30 | 108.64 | -0.10 | -18,385 | -17 | |
2023Q1 | 3.03 | 107.88 | -0.10 | -17,413 | -16 | |
2022Q4 | 2.33 | 104.34 | -0.14 | -22,562 | -22 | |
2022Q3 | 1.91 | 103.93 | -0.12 | -17,811 | -18 | |
2022Q2 | 2.71 | 102.91 | -0.09 | -14,109 | -14 | |
2022Q1 | 2.98 | 101.47 | -0.11 | -10,974 | -16 | |
2021Q4 | 3.89 | 100.17 | -0.15 | -20,796 | -21 | |
2021Q3 | 4.29 | 100.07 | -0.24 | -18,408 | -19 | |
2021Q2 | 3.03 | 100.10 | -0.23 | -18,642 | -19 | |
2021Q1 | 3.33 | 100.43 | -0.21 | -15,676 | -16 | |
2020Q4 | 3.55 | 100.34 | -0.23 | -16,301 | -17 | |
2020Q3 | 3.13 | 100.54 | -0.28 | -15,217 | -19 | |
2020Q2 | 1.82 | 101.18 | -0.24 | -13,141 | -14 | |
2020Q1 | 1.01 | 102.55 | -0.25 | -13,147 | -14 |